812.212.1MPLOFederal Council OrdinanceJan 1, 2019Original source
Swissmedic may withdraw the licence in the interest of protecting patients’ health.
The announcement of a final Swissmedic decision rejecting the application for a licence to place the medicinal product on the market leads to withdrawal of the licence.
If Swissmedic authorises the marketing of the medicinal product, the temporary licence to use the product ends when the medicinal product is actually supplied. The sponsor informs Swissmedic of the time at which the medicinal product is actually supplied.
0 commentaries
No commentaries are available for this article yet.